Clinical Case Reports (May 2022)

The usefulness of OK‐432 for the treatment of postoperative chylothorax in a low‐birth‐weight infant with trisomy 18

  • Yoshiaki Takahashi,
  • Yoshiaki Kinoshita,
  • Takashi Kobayashi,
  • Yuhki Arai,
  • Toshiyuki Ohyama,
  • Naoki Yokota,
  • Koichi Saito,
  • Yu Sugai,
  • Shoichi Takano

DOI
https://doi.org/10.1002/ccr3.5844
Journal volume & issue
Vol. 10, no. 5
pp. n/a – n/a

Abstract

Read online

Abstract Chylothorax is a rare but life‐threatening condition in neonates. We herein report the successful use of OK‐432 for a low‐birth‐weight infant with trisomy 18 who developed refractory chylothorax after thoracic surgery. Increasing the concentration of OK‐432 seems useful in cases with a lot of pleural effusion.

Keywords